Alpha Tau Medical Ltd. (DRTS)

Alpha Tau Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	22.99	12.2	13.72	12.66	5.84	23.24
Short-Term Investments	77.65	60.92	45.88	69.13	98.69	8.08
Cash & Short-Term Investments	100.64	73.13	59.6	81.79	104.53	31.32
Cash Growth	26.27%	22.70%	-27.13%	-21.76%	233.79%	-31.94%
Other Receivables	-	0.34	0.33	0.34	0.31	0.48
Receivables	-	0.34	0.33	0.34	0.31	0.48
Prepaid Expenses	2.06	1.06	1.04	0.47	0.78	0.23
Restricted Cash	-	-	-	-	0.85	0.62
Other Current Assets	4.13	3.78	3.26	3.15	-	-
Total Current Assets	106.83	78.3	64.23	85.76	106.48	32.64
Property, Plant & Equipment	26.89	26.88	21.54	21.16	13.28	7.55
Other Long-Term Assets	0.53	0.48	0.43	0.47	0.39	2.03
Total Assets	134.25	105.65	86.2	107.39	120.15	42.22

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	3.17	3.87	3.53	2.57	1.42	1.2
Accrued Expenses	5.15	5.51	4.13	3.4	2.18	3.15
Current Portion of Leases	1.32	1.13	1.01	1.06	0.67	-
Other Current Liabilities	-	-	-	0.08	0.06	0.05
Total Current Liabilities	9.63	10.51	8.68	7.1	4.34	4.41
Long-Term Debt	6.8	6.35	5.56	5.61	-	-
Long-Term Leases	7.03	6.24	5.96	6.6	4.52	-
Long-Term Deferred Tax Liabilities	0.31	0.1	-	-	-	-
Other Long-Term Liabilities	47.54	5.35	3.34	3.6	5.63	-
Total Liabilities	90.2	28.55	23.54	22.91	14.49	4.41

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Additional Paid-In Capital	302.94	267.24	210.18	200.23	192.26	18.06
Retained Earnings	-258.89	-190.14	-147.51	-115.76	-86.6	-52.84
Total Common Equity	44.06	77.1	62.67	84.48	105.66	-34.78
Shareholders' Equity	44.06	77.1	62.67	84.48	105.66	37.81
Total Liabilities & Equity	134.25	105.65	86.2	107.39	120.15	42.22

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	15.15	13.73	12.54	13.28	5.19	-
Net Cash (Debt)	85.49	59.4	47.06	68.51	99.34	31.32
Net Cash Growth	28.78%	26.21%	-31.30%	-31.03%	217.21%	-31.94%
Net Cash Per Share	0.97	0.74	0.67	0.99	1.56	0.77
Filing Date Shares Outstanding	92.33	88.01	70.38	69.67	69.13	66.53
Total Common Shares Outstanding	92.33	88.01	70.38	69.67	69.11	40.53
Working Capital	97.2	67.79	55.55	78.65	102.14	28.24
Book Value Per Share	0.48	0.88	0.89	1.21	1.53	-0.86
Tangible Book Value	44.06	77.1	62.67	84.48	105.66	-34.78
Tangible Book Value Per Share	0.48	0.88	0.89	1.21	1.53	-0.86
Land	-	5.25	5.25	5.25	-	-
Machinery	-	19.68	10.74	10.52	9.36	8.46
Construction In Progress	-	-	2	-	-	-

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Aug 10, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 31, 2026

Data Sources Report a data error